Left Atrial Appendage Closure Devices Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32
                     Global Left Atrial 
Appendage Closure Devices 
Market Research and 
Forecast Report 2024-2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
Accord ing  t o  the  la tes t  repo r t  by  IMARC Group,  t i t l ed  "Lef t  At r ia l  Appendage  
C losure  Devi ces  Market :  G l obal  I ndust ry  T rends,  Share ,  S i ze ,  Growth ,  
Oppor tun i ty  and  Forecast  2024-2032 ,"  t he  g loba l  l e f t  a t r ia l  appendage  c losure  
dev ices  marke t  s i ze  reached  US$  1 .5  B i l l i on  in  2023.
Report Le f t  a t r i a l  appendage c losure  (LAAC)  dev ices  a re  med ica l  im p lan ts  t ha t  p reven t  s t rokes  among  pa t i en ts  w i t h  a t r ia l  f i b r i l l a t ion ,  a  comm on hear t  r hy t hm d iso rder .  
They  a re  des igned  t o  sea l  o f f  t h i s  a rea ,  wh ich  reduces  t he  r i sk  o f  c l o t s  escap ing  
Highlight and and  caus ing  b lockages  in  t he  b ra in .  They  can  be  per fo rmed by  a  spec ia l i s t  us ing  
ca the te r i za t ion  techn iques .  
Description They  o f f e r  an  a l t e rna t i ve  t o  long- te rm b lood- th inn ing  med ica t ion ,  wh ich  makes  them a  va luab le  op t i on  fo r  t hose  who  canno t  t o l e ra t e  such  d rugs ,  and  prevent s  
the  fo rma t i on  and  m igra t i on  o f  c lo t s .  They  have been  e f fec t i ve  in  s t roke  
prevent ion  and have become an  essen t ia l  t oo l  in  ca rd iac  ca re .
Request  fo r  a  PDF sample  o f  th is  repor t :  
ht tps : / / www. imarcgroup .com/ le f t - a t r ia l - appendage-c losure-dev ices -marke t / r eques t
samp le
Report Description
Global  Lef t  A t r ia l  Appendage C losure  Dev ices  Market  T rends:
The  inc reas ing  number  o f  a t r ia l  f i b r i l l a t ion  cases  among  t he  masses  and the  r i s ing  o lder  popu la t ion  tha t  i s  more  
suscept ib le  to  hea r t  d i seases  rep resen t  one  o f  t he  ma jo r  f ac to rs  d r i v ing  the  demand  fo r  LAAC dev ices  a round the  
wor l d .  Moreover ,  t he  g row ing  awareness  and educat ion  among  peop le  abou t  a t r ia l  f i b r i l l a t ion  and  LAAC so lu t ions  a re  
in f luenc ing  the  marke t  pos i t i ve ly .  
I n  add i t i on ,  t he  i nc reas ing  number  o f  c l i n i ca l  t r i a l s  t ha t  p rove  t he  e f f i cacy  o f  LAAC dev ices  and the  ongo ing  research  
and deve lopmen t  (R&D)  ac t i v i t i es  by  key  p laye rs  a re  augmen t i ng  t he  m arke t  g rowt h .  Apar t  f r om th is ,  t he  g row ing  
adop t ion  o f  LAAC dev ices  t o  p rov ide  a  m in ima l l y  i nvas ive  surg ica l  (M I S )  p rocedure  a l t e rna t i ve  t o  long - te rm 
med ica t ion ,  wh ich  makes  t hem pre fe rab le  f o r  many  pa t ien t s ,  i s  c rea t ing  a  pos i t i ve  ou t l ook  fo r  t he  marke t .
Look ing  fo rward ,  the  market  va lue  i s  p ro j ec ted  to  reach  US$  6 . 3  B i l l ion  by 2032 ,  expand i ng  a t  a  CAGR o f  
16 .85% dur ing  2024-2032 .
V i ew Repor t  TOC,  F igures  and Tab l es :  
h t tps : / /www. imarcgroup . com/ l e f t - a t r i a l -appendage-c losure -dev i ces-market
Product Insights:
• Endocardial  LAA Devices
• Epicardial  LAA Devices
 
End User Insights:
• Hospitals
• Ambulatory Surgery Centers
Report 
• Others
Segmentation
Regional Insights:
• North America
• Asia-Pacifi c
• Europe
• Lat in America
• Middle East and Afr ica
• Abbott Laboratories
• AtriCure Inc.
• Boston Scient ifi c Corporation
Competitive • Cardia Inc.
Landscape • Lepu Medical Technology (Bei j ing) Co. Ltd.
•
with Key LifeTech Scientifi c
Players
How has the global left atrial appendage closure 
devices market performed so far, and how will it 
perform in the coming years?
What are the drivers, restraints, and opportunities in 
the global left atrial appendage closure devices 
market?
Key What is the impact of each driver, restraint, and opportunity on the global left atrial appendage closure 
devices market?
Questions 
Answered in What are the key regional markets?
the Report
Which countries represent the most attractive left atrial 
appendage closure devices market?
What is the breakup of the market based on the 
product?
Which is the most attractive product in the left atrial 
appendage closure devices market?
What is the breakup of the market based on the end 
user?
Which is the most attractive end user in the left atrial 
appendage closure devices market?
Key 
What is the competitive structure of the global left 
atrial appendage closure devices market?
Questions 
Answered in Who are the key players/companies in the global left atrial appendage closure devices market?
the Report
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
        2 . 4 . 1     B o t t o m - U p  A p p r o a c h
Table of         2 . 4 . 2     T o p - D o w n  A p p r o a c h    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
    4 . 1     O v e r v i e w
Contents     4 . 2     K e y  I n d u s t r y  T r e n d s5     G l o b a l  L e f t  A t r i a l  A p p e n d a g e  C l o s u r e  D e v i c e s  M a r k e t
    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  F o r e c a s t
6      M a r k e t  B r e a k u p  b y  P r o d u c t
    6 . 1     E n d o c a r d i a l  L A A  D e v i c e s
        6 . 1 . 1  M a r k e t  T r e n d s
        6 . 1 . 2  M a r k e t  F o r e c a s t
    6 . 2     E p i c a r d i a l  L A A  D e v i c e s
        6 . 2 . 1  M a r k e t  T r e n d s
        6 . 2 . 2  M a r k e t  F o r e c a s t
7    M a r k e t  B r e a k u p  b y  E n d  U s e r
    7 . 1     H o s p i t a l s
        7 . 1 . 1  M a r k e t  T r e n d s
        7 . 1 . 2  M a r k e t  F o r e c a s t
       
    7 . 2     A m b u l a t o r y  S u r g e r y  C e n t e r s
        7 . 2 . 1  M a r k e t  T r e n d s
        7 . 2 . 2  M a r k e t  F o r e c a s t
    7 . 3     O t h e r s
        7 . 3 . 1  M a r k e t  T r e n d s
        7 . 3 . 2  M a r k e t  F o r e c a s t
8    M a r k e t  B r e a k u p  b y  R e g i o n
    8 . 1     N o r t h  A m e r i c a
        8 . 1 . 1  U n i t e d  S t a t e s
           8 . 1 . 1 . 1  M a r k e t  T r e n d s
Table of            8 . 1 . 1 . 2  M a r k e t  F o r e c a s t        8 . 1 . 2  C a n a d a
           8 . 1 . 2 . 1  M a r k e t  T r e n d s
           8 . 1 . 2 . 2  M a r k e t  F o r e c a s t
Contents     8 . 2     A s i a - P a c i f i c        8 . 2 . 1  C h i n a
           8 . 2 . 1 . 1  M a r k e t  T r e n d s
           8 . 2 . 1 . 2  M a r k e t  F o r e c a s t
        8 . 2 . 2  J a p a n
           8 . 2 . 2 . 1  M a r k e t  T r e n d s
           8 . 2 . 2 . 2  M a r k e t  F o r e c a s t
        8 . 2 . 3  I n d i a
           8 . 2 . 3 . 1  M a r k e t  T r e n d s
           8 . 2 . 3 . 2  M a r k e t  F o r e c a s t
        8 . 2 . 4  S o u t h  K o r e a
           8 . 2 . 4 . 1  M a r k e t  T r e n d s
           8 . 2 . 4 . 2  M a r k e t  F o r e c a s t
        8 . 2 . 5  A u s t r a l i a
           8 . 2 . 5 . 1  M a r k e t  T r e n d s
           8 . 2 . 5 . 2  M a r k e t  F o r e c a s t
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
h t t p s : / / w w w. i m a rc g ro u p . c o m / l e f t - a t r i a l - a p p e n d a g e - c l o s u re - d e v i c e s
- m a r ke t / t o c
Disclaimer
© 2023  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
TELEPHONE: +1-631-791-1145 
E-MAIL: [email protected]